Cardiology Practice Questions

Q: Recurrent ischemic events following thrombolysis have been pathophysiologically linked to which of the following factors?

Fibrinopeptide A. The correct answer is **Fibrinopeptide A**. **Pathophysiological Basis:** Thrombolytic therapy (like Streptokinase or tPA) aims to dissolve an occluding clot by converting plasminogen to plasmin [1, 3]. However, this process is paradoxically associated with a **prothrombotic state**. When a clot is lysed, "clot-bound" thrombin is released into the systemic circulation. This active thrombin acts on fibrinogen to produce **Fibrinopeptide A**, a sensitive biochemical marker of active thrombin generation and fibrin formation [3]. Elevated levels of Fibrinopeptide A indicate ongoing thrombogenesis, which significantly increases the risk of re-occlusion and recurrent ischemic events immediately following successful thrombolysis. **Analysis of Incorrect Options:** * **Triglycerides (A):** While elevated triglycerides are a long-term risk factor for atherosclerosis, they do not play an acute role in post-thrombolysis re-occlusion. * **Lipoprotein (a) (C):** High Lp(a) levels are associated with increased cardiovascular risk due to its structural similarity to plasminogen (inhibiting fibrinolysis), but it is not the specific marker linked to recurrent ischemia post-thrombolysis. * **Antibodies to thrombolytic agents (D):** While antibodies (especially against Streptokinase) can neutralize the drug and reduce its efficacy in *subsequent* administrations, they are not the primary cause of acute recurrent ischemia after the initial drug has already exerted its effect [4]. **High-Yield Pearls for NEET-PG:** * **The "Thrombin Paradox":** Thrombolysis successfully lyses the clot but simultaneously creates a highly thrombogenic environment by releasing bound thrombin. * To counteract this, **adjunctive anticoagulation** (e.g., Heparin) and **antiplatelet therapy** (e.g., Aspirin) are mandatory post-thrombolysis to prevent re-infarction. * **Fibrinopeptide A** is considered a "molecular marker of hemostatic activation."

Q: What is the level of LDL cholesterol at which therapy should be initiated in a patient without coronary artery disease and no risk factors?

190 mg/dL. The management of dyslipidemia is guided by the patient’s overall cardiovascular risk profile. According to the **ACC/AHA guidelines**, the threshold for initiating pharmacological therapy (statins) depends on the presence of Atherosclerotic Cardiovascular Disease (ASCVD), diabetes, or specific LDL levels. **1. Why 190 mg/dL is correct:** In a primary prevention patient (no clinical CAD) with **no other risk factors** (e.g., hypertension, smoking, low HDL, or diabetes), the threshold for automatic initiation of high-intensity statin therapy is an **LDL-C ≥ 190 mg/dL**. At this level, the risk of a cardiovascular event is high enough to warrant treatment regardless of the calculated 10-year ASCVD risk score, as it often suggests a genetic predisposition like Familial Hypercholesterolemia. **2. Why other options are incorrect:** * **100 mg/dL:** This is the traditional "optimal" level. It is the treatment target for very high-risk patients with established CAD [1], but not a threshold for starting therapy in healthy individuals. * **130 mg/dL:** This is considered "borderline high." Therapy at this level is usually only considered if the patient has multiple risk factors or a high 10-year ASCVD risk score (>7.5% to 20%) [1]. * **160 mg/dL:** While "high," in the absence of any risk factors, lifestyle modifications are prioritized over immediate pharmacotherapy unless the level crosses the 190 mg/dL mark. **High-Yield Clinical Pearls for NEET-PG:** * **Diabetes Mellitus:** In patients aged 40–75 with DM, statins are started if LDL is **>70 mg/dL**, regardless of the 10-year risk. * **Statins:** They are the first-line agents; they work by inhibiting **HMG-CoA reductase** [2]. * **Rule of 5:** For every 40 mg/dL (1 mmol/L) reduction in LDL, there is a ~20% reduction in major cardiovascular events.

Q: A 55-year-old woman with a recent diagnosis of amyloidosis presents with increasing shortness of breath, fatigue, and edema. Examination reveals a JVP of 10 cm with prominent x and y descents but a negative Kussmaul's sign. Her blood pressure is 90/70 mm Hg, pulse is 100/min with low volume, and there is no pulsus paradoxus or abnormal heart sounds. What is the most likely diagnosis for this patient presenting with shortness of breath and peripheral edema?

Restrictive cardiomyopathy. The patient presents with signs of right-sided heart failure (elevated JVP, edema) in the setting of systemic amyloidosis [1]. The key to differentiating these cardiac pathologies lies in the JVP waveform and physical exam findings. **1. Why Restrictive Cardiomyopathy (RCM) is correct:** Amyloidosis is the most common cause of RCM. In RCM, the ventricles are stiff, leading to impaired diastolic filling. This results in **prominent 'x' and 'y' descents** in the JVP. Crucially, **Kussmaul’s sign** (a paradoxical rise in JVP during inspiration) is typically **absent** in RCM (unlike Constrictive Pericarditis), and there is no pulsus paradoxus. **2. Why the other options are incorrect:** * **Cardiac Tamponade:** Characterized by Beck’s Triad (hypotension, muffled heart sounds, elevated JVP) [2]. However, it features a **blunted 'y' descent** (due to impaired diastolic filling) and **pulsus paradoxus**, both of which are absent here. [2] * **Constrictive Pericarditis (CP):** While CP also shows prominent 'x' and 'y' descents (Friedreich’s sign), it is classically associated with a **positive Kussmaul’s sign** [3] and often a pericardial knock. * **RV Myocardial Infarction:** Usually presents acutely with clear lungs and hypotension [4]. While it shows elevated JVP and Kussmaul’s sign, it is not associated with the chronic infiltrative history of amyloidosis. **High-Yield Clinical Pearls for NEET-PG:** * **Amyloidosis + Low Voltage ECG + Thickened Ventricles on Echo** = Pathognomonic for Restrictive Cardiomyopathy. * **JVP Waveforms:** * *Tamponade:* Absent 'y' descent. [2] * *Constrictive Pericarditis/RCM:* Prominent 'y' descent. * **Kussmaul’s Sign:** Seen in Constrictive Pericarditis, RV Infarction, and Tricuspid Stenosis; usually absent in Cardiac Tamponade and RCM.

Q: Ventricular aneurysm has one of the following characteristic features?

Persistent ST segment elevation. ### Explanation **Correct Answer: A. Persistent ST segment elevation** **Mechanism:** A ventricular aneurysm is a late complication of a transmural myocardial infarction (MI), occurring in approximately 5–10% of patients [1]. It results from the thinning and stretching of the infarcted myocardial wall, which becomes fibrotic and non-contractile (dyskinetic). The hallmark ECG finding is **persistent ST-segment elevation** (usually in the precordial leads) that remains present for **more than 6 weeks** following an acute MI [1]. This occurs because the fibrotic, scarred tissue creates a "current of injury" or mechanical stress at the border zone between the aneurysm and the viable myocardium [2]. Unlike an acute MI, these ST elevations are typically stable over time and are not accompanied by reciprocal changes or evolving T-wave inversions. **Why other options are incorrect:** * **B. Persistent ST segment depression:** This is usually a sign of subendocardial ischemia or digitalis effect, not a structural aneurysm. * **C & D. LBBB and RBBB:** While bundle branch blocks can occur post-MI due to septal damage, they are not specific or diagnostic features of a ventricular aneurysm. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Site:** The **apex** of the left ventricle (associated with LAD occlusion). * **Physical Exam:** Look for a **"double apical impulse"** or a diffuse, displaced apical beat [1]. * **Imaging:** Echocardiography is the gold standard for diagnosis, showing a localized area of **dyskinesia** (paradoxical bulging during systole) [1]. * **Complications:** Systemic embolism (due to mural thrombus), refractory heart failure, and ventricular arrhythmias [1]. * **Distinction:** Unlike a *pseudoaneurysm* (which is a contained rupture with a high risk of bursting), a true aneurysm rarely ruptures because it is composed of tough fibrous tissue.

Q: A patient presented with pulsating varicose veins of the lower limb. What is the most probable diagnosis?

Klippel Trenaunay syndrome. ### Explanation **Correct Answer: A. Klippel Trenaunay Syndrome (KTS)** The hallmark of **Klippel Trenaunay Syndrome** is a triad of: 1. **Port-wine stain** (Capillary malformations) 2. **Soft tissue and bony hypertrophy** of the affected limb 3. **Atypical varicose veins** The presence of **pulsating varicose veins** in KTS is due to the underlying **Arteriovenous (AV) malformations/fistulae**. These high-pressure arterial communications transmit pulsations directly into the low-pressure venous system, causing the veins to pulsate and dilate. --- ### Why the other options are incorrect: * **B. Tricuspid Regurgitation (TR):** While severe TR causes systolic pulsations, these are typically seen in the **Internal Jugular Vein (IJV)** and the **liver** (pulsatile hepatomegaly). It does not typically cause localized pulsating varicose veins in the lower limbs. * **C. Deep Vein Thrombosis (DVT):** DVT presents with calf pain, swelling, and warmth [1]. While it can lead to secondary varicose veins (Post-thrombotic syndrome) due to venous hypertension, these veins do **not** pulsate. * **D. Right Ventricular Failure (RVF):** RVF leads to systemic venous congestion, manifesting as elevated JVP, pedal edema, and ascites. While it may exacerbate existing varicosities, it does not impart a pulsatile quality to them. --- ### High-Yield Clinical Pearls for NEET-PG: * **Parkes-Weber Syndrome:** Similar to KTS but specifically characterized by significant, high-flow AV fistulae. Some examiners use KTS and Parkes-Weber interchangeably when discussing pulsating veins. * **Kasabach-Merritt Syndrome:** A potential complication of large vascular malformations where platelets are sequestered, leading to consumptive coagulopathy. * **Diagnosis:** Color Doppler is the initial investigation of choice to identify AV communications. MRI/MRA is used for definitive anatomical mapping.

Q: What is the severity of mitral regurgitation (MR)?

Severe MR. ***Severe MR*** - **Severe mitral regurgitation** is defined by specific echocardiographic criteria including **regurgitant jet area >40% of left atrial area**, **vena contracta ≥0.7 cm**, and **effective regurgitant orifice area (EROA) ≥0.4 cm²**. - Additional criteria include **regurgitant volume ≥60 mL** and **regurgitant fraction ≥50%** per **ASE/ACC/AHA guidelines**, indicating significant hemodynamic impact. *Profound MR* - **"Profound MR"** is not a recognized clinical grading term in standard echocardiographic classification systems. - Current guidelines use a **four-tier system**: mild, moderate, severe, and sometimes **torrential** for the most extreme cases, but "profound" is not part of established terminology. *Moderate MR* - **Moderate MR** is characterized by **regurgitant jet area 20-40% of left atrial area** and **vena contracta 0.3-0.69 cm**. - **EROA ranges 0.2-0.39 cm²** with **regurgitant volume 30-59 mL** and **regurgitant fraction 30-49%**. *Mild MR* - **Mild MR** shows **regurgitant jet area <20% of left atrial area** and **vena contracta <0.3 cm**. - **EROA is <0.2 cm²** with **regurgitant volume <30 mL** and **regurgitant fraction <30%**, indicating minimal hemodynamic significance.

Q: A 45-year-old smoker presents with sudden onset unrelenting chest pain and loss of peripheral pulses. Blood pressure measured in both arms is different. What is the most likely first differential diagnosis?

Aortic dissection. The clinical presentation of sudden, unrelenting chest pain associated with a **blood pressure discrepancy** between the arms and **loss of peripheral pulses** is a classic triad for **Aortic Dissection** [1]. **1. Why Aortic Dissection is correct:** Aortic dissection occurs when a tear in the tunica intima allows blood to surge into the media, creating a "false lumen." As the dissection propagates, it can involve the origins of major arteries (like the subclavian or iliac arteries). This leads to **malperfusion syndrome**, manifesting as asymmetrical blood pressure readings (typically a difference >20 mmHg) and absent or diminished peripheral pulses. The pain is usually described as "tearing" or "ripping" and radiates to the back [1]. **2. Why other options are incorrect:** * **Mirizzi Syndrome:** This is a rare complication of gallstone disease where a stone in the cystic duct compresses the common hepatic duct, causing obstructive jaundice. It has no correlation with chest pain or pulse deficits. * **Viral Pericarditis:** Presents with pleuritic chest pain that improves upon leaning forward [2]. It does not cause pulse deficits or BP discrepancies. * **Spontaneous Pneumothorax:** Presents with sudden chest pain and dyspnea with decreased breath sounds on the affected side. While it can cause hypotension (if tension develops), it does not cause asymmetrical limb pressures. **Clinical Pearls for NEET-PG:** * **Gold Standard Investigation:** CT Angiography (CTA) is the investigation of choice in stable patients. Transesophageal Echocardiogram (TEE) is preferred in unstable patients. * **Stanford Classification:** Type A involves the ascending aorta (Surgical emergency); Type B involves only the descending aorta (Medical management) [1]. * **Risk Factors:** Hypertension (most common), Marfan Syndrome, and smoking [1]. * **Chest X-ray:** May show a "widened mediastinum" (seen in ~80% of cases).

Q: Paradoxical embolism is detected by?

Bubble contrast Echocardiography. **Explanation:** **Paradoxical embolism** occurs when a thrombus originating in the systemic venous circulation (e.g., DVT) bypasses the lungs and enters the systemic arterial circulation through a **Right-to-Left shunt**, most commonly a **Patent Foramen Ovale (PFO)** or an Atrial Septal Defect (ASD). **Why Bubble Contrast Echocardiography is correct:** Agitated saline (bubble contrast) is the gold standard bedside screening tool for detecting these shunts. During the procedure, saline is agitated to create microbubbles and injected into a peripheral vein. In a normal heart, these bubbles are filtered out by the pulmonary capillary bed. However, in the presence of a right-to-left shunt, the bubbles appear in the **left atrium/ventricle** within 3 to 6 cardiac cycles. Performing a **Valsalva maneuver** increases right atrial pressure, further enhancing the sensitivity of the test by forcing the shunt open. **Analysis of Incorrect Options:** * **MRI and CT Chest:** While useful for diagnosing pulmonary emboli or structural lung disease, they are not dynamic enough to visualize the real-time transit of microbubbles across a septal defect. * **Impedance Plethysmography:** This is an older, non-invasive method used to detect Deep Vein Thrombosis (DVT) by measuring changes in electrical resistance related to blood flow in the leg. It cannot detect intracardiac shunts. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard for PFO:** Transesophageal Echocardiography (TEE) with bubble contrast is more sensitive than Transthoracic Echocardiography (TTE). * **Platypnea-Orthodeoxia Syndrome:** A rare condition where a patient experiences dyspnea and deoxygenation when upright, often associated with a PFO. * **Cryptogenic Stroke:** Paradoxical embolism should be suspected in young patients presenting with a stroke and no identifiable arterial risk factors.

Q: Which congenital heart disease is associated with pre-excitation?

Ebstein's Anomaly. **Explanation:** **Ebstein’s Anomaly** is the correct answer because it has a unique anatomical and physiological association with **Wolff-Parkinson-White (WPW) Syndrome**. In Ebstein’s anomaly, there is a failure of delamination of the tricuspid valve leaflets, leading to their downward displacement into the right ventricle ("atrialization" of the RV). This structural abnormality is frequently accompanied by **accessory atrioventricular pathways** (bundles of Kent), particularly on the right side of the heart. Approximately 10–25% of patients with Ebstein’s anomaly exhibit pre-excitation on ECG (short PR interval and Delta waves), making them prone to supraventricular tachycardias. **Analysis of Incorrect Options:** * **Atrial Septal Defect (ASD):** While ASD is the most common CHD associated with Ebstein’s anomaly, an isolated ASD typically presents with a Right Bundle Branch Block (RBBB) pattern, not pre-excitation. * **Bicuspid Aortic Valve:** This is the most common congenital heart anomaly overall. It is associated with aortic stenosis, regurgitation, and Turner syndrome, but not with accessory conduction pathways. * **Patent Ductus Arteriosus (PDA):** This is an extracardiac shunt between the aorta and pulmonary artery. It causes a continuous machinery murmur but does not involve the cardiac conduction system. **High-Yield Clinical Pearls for NEET-PG:** * **ECG Findings in Ebstein’s:** Giant "Himalayan" P-waves (right atrial enlargement), RBBB, and pre-excitation (WPW). * **Auscultation:** Characterized by a "split" S1 (loud tricuspid closure or "sail sound") and a quadruple gallop rhythm. * **Maternal Link:** Classically associated with maternal **Lithium** intake during the first trimester. * **X-ray:** Shows a massive, "box-shaped" heart due to severe right atrial enlargement.

Q: A 70-year-old man presents with isolated systolic hypertension. His blood pressure is 170/80 mm Hg, and physical examination reveals normal heart and lungs. He has no other medical conditions. For a patient with high blood pressure, select the most appropriate medication.

Thiazides. **Explanation:** **1. Why Thiazides are correct:** The patient presents with **Isolated Systolic Hypertension (ISH)**, defined as a systolic BP ≥140 mmHg with a diastolic BP <90 mmHg. This condition is common in the elderly due to age-related arterial stiffness and decreased compliance of the aorta [1]. Large-scale clinical trials (such as SHEP and ALLHAT) have established **Thiazide-type diuretics** (e.g., Chlorthalidone, Hydrochlorothiazide) and **Calcium Channel Blockers (CCBs)** as the first-line agents for ISH. They are highly effective in reducing stroke risk and cardiovascular events in this specific demographic [1]. **2. Why the other options are incorrect:** * **Spironolactone (B):** This is a potassium-sparing diuretic/mineralocorticoid receptor antagonist. It is typically used as an add-on therapy (4th line) in resistant hypertension or in patients with heart failure (HFrEF). * **Clonidine (C):** A centrally acting alpha-2 agonist. It is not a first-line agent due to its side effect profile (sedation, dry mouth) and the risk of severe rebound hypertension if doses are missed. * **Prazosin (D):** An alpha-1 blocker. It is associated with "first-dose hypotension" and is not a primary choice for ISH [2]. It is generally reserved for hypertensive patients with concomitant Benign Prostatic Hyperplasia (BPH). **3. NEET-PG High-Yield Pearls:** * **Definition of ISH:** Widened pulse pressure (Systolic ↑, Diastolic normal/low) [1]. * **Drug of Choice (DOC):** Thiazides or Long-acting Dihydropyridine CCBs (e.g., Amlodipine) [1]. * **Thiazide Side Effects:** Remember the "Hypo-Hyper" rule: **Hypo**kalemia, **Hypo**natremia, **Hyper**uricemia, **Hyper**calcemia, and **Hyper**glycemia. * **JNC-8 Guidelines:** For the general elderly population (≥60 years), the BP goal is <150/90 mmHg, though more recent guidelines (ACC/AHA) suggest stricter targets (<130/80 mmHg) if tolerated.

Question 1

Recurrent ischemic events following thrombolysis have been pathophysiologically linked to which of the following factors?

Accepted Answer

Fibrinopeptide A

Answer

Triglycerides

Answer

Lipoprotein (a)

Answer

Antibodies to thrombolytic agents

Question 2

What is the level of LDL cholesterol at which therapy should be initiated in a patient without coronary artery disease and no risk factors?

Accepted Answer

190 mg/dL

Answer

100 mg/dL

Answer

130 mg/dL

Answer

160 mg/dL

Question 3

A 55-year-old woman with a recent diagnosis of amyloidosis presents with increasing shortness of breath, fatigue, and edema. Examination reveals a JVP of 10 cm with prominent x and y descents but a negative Kussmaul's sign. Her blood pressure is 90/70 mm Hg, pulse is 100/min with low volume, and there is no pulsus paradoxus or abnormal heart sounds. What is the most likely diagnosis for this patient presenting with shortness of breath and peripheral edema?

Accepted Answer

Restrictive cardiomyopathy

Answer

Cardiac tamponade

Answer

Constrictive pericarditis

Answer

Right ventricle myocardial infarction

Question 4

Ventricular aneurysm has one of the following characteristic features?

Accepted Answer

Persistent ST segment elevation

Answer

Persistent ST segment depression

Answer

Left bundle branch block

Answer

Right bundle branch block

Question 5

A patient presented with pulsating varicose veins of the lower limb. What is the most probable diagnosis?

Accepted Answer

Klippel Trenaunay syndrome

Answer

Tricuspid regurgitation

Answer

Deep Vein Thrombosis (DVT)

Answer

Right ventricular failure

Question 6

What is the severity of mitral regurgitation (MR)?

Accepted Answer

Severe MR

Answer

Profound MR

Answer

Moderate MR

Answer

Mild MR

Question 7

A 45-year-old smoker presents with sudden onset unrelenting chest pain and loss of peripheral pulses. Blood pressure measured in both arms is different. What is the most likely first differential diagnosis?

Accepted Answer

Aortic dissection

Answer

Mirizzi syndrome

Answer

Viral pericarditis

Answer

Spontaneous pneumothorax

Question 8

Paradoxical embolism is detected by?

Accepted Answer

Bubble contrast Echocardiography

Answer

MRI Chest

Answer

CT scan Chest

Answer

Impedance plethysmography

Question 9

Which congenital heart disease is associated with pre-excitation?

Accepted Answer

Ebstein's Anomaly

Answer

Atrial Septal Defect

Answer

Bicuspid Aortic Valve

Answer

Patent Ductus Arteriosus

Question 10

A 70-year-old man presents with isolated systolic hypertension. His blood pressure is 170/80 mm Hg, and physical examination reveals normal heart and lungs. He has no other medical conditions. For a patient with high blood pressure, select the most appropriate medication.

Accepted Answer

Thiazides

Answer

Spironolactone

Answer

Clonidine

Answer

Prazosin

Cardiology — MCQs

Cardiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?